Cargando…

Association between angiotensin II receptor type 1 A1166C polymorphism and chronic kidney disease

Studies of the association between angiotensin II receptor type 1 A1166C (AGTR1 A1166C) polymorphism and chronic kidney disease (CKD) risk have yielded conflicting results. We conducted a combined case-control study and meta-analysis to better define this association. The case-control study included...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Hsien-Feng, Hsiao, Po-Jen, Hsu, Yu-Juei, Lin, Fu-Huang, Lin, Chin, Su, Wen, Chen, Hsiang-Cheng, Su, Sui-Lung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865681/ https://www.ncbi.nlm.nih.gov/pubmed/29581855 http://dx.doi.org/10.18632/oncotarget.24469

Ejemplares similares

Angiotensin II receptor type 1 A1166C modifies the association between angiotensinogen M235T and chronic kidney disease
por: Su, Sui-Lung, et al.
Publicado: (2017)

The Role of Angiotensin II Type 1 Receptor A1166C Polymorphism in Autosomal Dominant Polycystic Kidney Disease
por: Sasidharan, Anand, et al.
Publicado: (2023)

Angiotensin II Type 1 Receptor Gene A1166C Polymorphism Was Not Associated With Acute Coronary Syndrome in an Iranian Population
por: Delshad, Navid, et al.
Publicado: (2016)

Angiotensin II type 1 receptor A1166C gene polymorphism and essential hypertension in Calabar and Uyo cities, Nigeria
por: Kooffreh, Mary Esien, et al.
Publicado: (2013)

Angiotensin II type-1 receptor A1166C polymorphism is associated with increased risk of ischemic stroke in hypertensive smokers
por: Szolnoki, Zoltán, et al.
Publicado: (2006)

Association of Angiotensin-Converting Enzyme Intron 16 Insertion/Deletion and Angiotensin II Type 1 Receptor A1166C Gene Polymorphisms with Preeclampsia in South East of Iran
por: Salimi, Saeedeh, et al.
Publicado: (2011)

Coexistence of angiotensin II type-1 receptor A1166C and angiotensin-converting enzyme D/D polymorphism suggests susceptibility for small-vessel-associated ischemic stroke
por: Szolnoki, Zoltán, et al.
Publicado: (2006)

The Association between Angiotensin II Type 1 Receptor Gene A1166C Polymorphism and Non-alcoholic Fatty Liver Disease and Its Severity
por: Eshraghian, Ahad, et al.
Publicado: (2018)

Relationship between A1166C polymorphism of angiotensin II type 1 receptor gene and arteriosclerosis: A protocol for systematic review and meta-analysis
por: Shi, Zhongping, et al.
Publicado: (2021)

Association of angiotensin ІІ type 1 receptor gene A1166C polymorphism with cancer risk: An updated meta-analysis
por: Hu, Xue, et al.
Publicado: (2019)

Association of Angiotensin II Type 1 Receptor (A1166C) Gene Polymorphism and Its Increased Expression in Essential Hypertension: A Case-Control Study
por: Chandra, Sudhir, et al.
Publicado: (2014)

Fixed-Dose Combinations of Renin–Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors
por: Hsiao, Fu-Chih, et al.
Publicado: (2015)

Repositioning of the Angiotensin II Receptor Antagonist Candesartan as an Anti-Inflammatory Agent With NLRP3 Inflammasome Inhibitory Activity
por: Lin, Wen-Yu, et al.
Publicado: (2022)

Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Susceptibility to Osteoarthritis of the Knee: A Case-Control Study and Meta-Analysis
por: Lin, Chin, et al.
Publicado: (2016)

Angiotensin II receptor blockade is associated with preserved muscle strength in chronic hemodialysis patients
por: Lin, Yu-Li, et al.
Publicado: (2019)

Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism Contributes High Risk for Chronic Kidney Disease in Asian Male with Hypertension–A Meta-Regression Analysis of 98 Observational Studies
por: Lin, Chin, et al.
Publicado: (2014)

Investigation of the variants at the binding site of inflammatory transcription factor NF-κB in patients with end-stage renal disease
por: Yang, Jia-Hwa, et al.
Publicado: (2019)

Experience of 1166 Thyroidectomy without Use of Prophylactic Antibiotic
por: Lu, Qiang, et al.
Publicado: (2014)

Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population
por: Zheng, Cai-Mei, et al.
Publicado: (2019)

Association between nitric oxide synthase T-786C genetic polymorphism and chronic kidney disease: Meta-analysis incorporating trial sequential analysis
por: Hsiao, Po-Jen, et al.
Publicado: (2021)

Author Correction: Angiotensin-converting enzyme inhibitors or angiotensin receptor blocker monotherapy retard deterioration of renal function in Taiwanese chronic kidney disease population
por: Zheng, Cai-Mei, et al.
Publicado: (2020)

Endoscopic endonasal transsphenoidal surgery of 1,166 pituitary adenomas
por: Wang, Fuyu, et al.
Publicado: (2014)

Genetic polymorphism of ACE and the angiotensin II type1 receptor genes in children with chronic kidney disease
por: Elshamaa, Manal F, et al.
Publicado: (2011)

Mitochondrial protection by simvastatin against angiotensin II‐mediated heart failure
por: Hsieh, Chong‐Chao, et al.
Publicado: (2019)

Angiotensin Converting Enzyme and Angiotensin II Type 1 Receptor Polymorphisms in Patients with Coronary Aneurysms
por: Lamblin, Nicolas, et al.
Publicado: (2003)

Eprosartan mesylate, an angiotensin II receptor antagonist
por: Qian, Jing-Jing, et al.
Publicado: (2011)

Angiotensin Receptor-Neprilysin Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction and Advanced Chronic Kidney Disease: A Retrospective Multi-Institutional Study
por: Hsiao, Fu-Chih, et al.
Publicado: (2022)

Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade
por: Lin, Chih-Ching, et al.
Publicado: (2017)

Association of AGTR1 (A1166C) and ACE (I/D) Polymorphisms with Breast Cancer Risk in North Indian Population()
por: Singh, Anukriti, et al.
Publicado: (2018)

Association between AGTR1 A1166C polymorphism and the susceptibility to diabetic nephropathy: Evidence from a meta-analysis
por: Zhuang, Yan, et al.
Publicado: (2018)

Association of AGTR1 A1166C and CYP2C9∗3 Gene Polymorphisms with the Antihypertensive Effect of Valsartan
por: Liu, Yi, et al.
Publicado: (2022)

1166. Infection Rate in Venous–Venous Extracorporeal Membrane Oxygenation (VV-ECMO)
por: Wang, Joseph, et al.
Publicado: (2019)

1166. Evaluating the Impact of the 2016 Candidemia Guidelines on the Incidence of Ocular Complications of Candidemia
por: Hillenbrand, Molly, et al.
Publicado: (2020)

1166. Reverse Syphilis Screening and Adherence to The Congenital Syphilis Guidelines: Institutional Experience
por: Chatani, Brandon, et al.
Publicado: (2021)

Resistive index as a predictor of acute kidney injury caused by an angiotensin converting enzyme inhibitor or angiotensin II receptor blocker in chronic kidney disease patients
por: Kim, Eun Seok, et al.
Publicado: (2013)

Artificial Intelligence Learning Semantics via External Resources for Classifying Diagnosis Codes in Discharge Notes
por: Lin, Chin, et al.
Publicado: (2017)

Combination therapy of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chronic kidney disease
por: Vasavada, Nina, et al.
Publicado: (2009)

Angiotensin II Type 1 Receptor‐Associated Protein Regulates Kidney Aging and Lifespan Independent of Angiotensin
por: Uneda, Kazushi, et al.
Publicado: (2017)

Angiotensin 1-7 Receptor and Angiotensin II Receptor 2 Blockades Prevent the Increased Serum and Kidney Nitric Oxide Levels in Response to Angiotensin II Administration: Gender-Related Difference
por: Safari, Tahereh, et al.
Publicado: (2013)

Angiotensin II Receptor Blocker Associated With Less Outcome Risk in Patients With Acute Kidney Disease
por: Wu, Vin-Cent, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uco9b0tcnro48gto9rt79n7pdg